Department of Child Health, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
Department of Pediatrics, Royal Hospital, Muscat, Oman.
Pediatr Rheumatol Online J. 2021 Sep 9;19(1):141. doi: 10.1186/s12969-021-00619-w.
The ACR 1997, SLICC 2012 and EULAR/ACR 2019 classification criteria were validated based on adult patients. To date, there are no classification criteria specific for children with SLE. The aim of the study is to compare the performance characteristics among the three SLE classification criteria (ACR-1997, SLICC-2012 and EULAR/ACR-2019) in childhood onset SLE (cSLE) cohort of Arab ethnicity from Oman.
We conducted a retrospective multicenter study in Oman of cSLE patients as cases and patients with other rheumatic disease with a positive ANA titer as controls. The cSLE cases recruited were children diagnosed with SLE before 13 years of age. Data was retrospectively collected to establish the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria fulfilled at first visit, first year follow up and last follow up.
Study population included 113 cSLE cases (mean age at diagnosis of 7.3 ± 3.4 years with disease duration of 6.1 ± 4.6 years) and 51 controls (mean age at diagnosis 5.0 ± 3.4 with disease duration 5.7 ± 3.9). The cSLE cases had higher frequency of familial SLE than controls (38% vs 7.8%; p < 0.001). The performance measures demonstrated that EULAR/ACR-2019 criteria had the highest sensitivity (81, 88, 89%) compared to ACR 1997 (49, 57, 66%) and SLICC 2012 (76, 84,86%); while the ACR 1997 had the highest specificity (96%) compared to SLICC 2012 (94%) and EULAR/ACR 2019 (90%) at first visit, first year and last assessment. When we increased the threshold score to ≥13 rather than the traditional score ≥ 10 for ACR/EULAR 2019, there was increased specificity (96%) at the expense of lower sensitivity (76, 83, and 84%) at first visit, first year and last assessment.
In this cSLE population, EULAR/ACR 2019 scored better at initial presentation, first year and last assessment follow up. Further multinational studies are needed to validate the appropriate cut off score for the newly proposed ACR/EULAR 2019 classification criteria in cSLE to increase early sensitivity and specificity for cSLE classification.
ACR 1997、SLICC 2012 和 EULAR/ACR 2019 分类标准是基于成年患者进行验证的。迄今为止,尚无针对儿童系统性红斑狼疮 (SLE) 的特定分类标准。本研究的目的是比较三种 SLE 分类标准(ACR-1997、SLICC-2012 和 EULAR/ACR-2019)在阿拉伯血统的阿曼儿童发病的 SLE(cSLE)队列中的表现特征。
我们在阿曼进行了一项回顾性多中心研究,纳入了 cSLE 患者作为病例,并纳入了其他风湿病患者作为抗核抗体滴度阳性的对照。招募的 cSLE 病例为 13 岁以下确诊为 SLE 的儿童。数据是回顾性收集的,以确定在首次就诊、首次随访和末次随访时满足 ACR-1997、SLICC-2012 和 EULAR/ACR-2019 标准的情况。
研究人群包括 113 例 cSLE 病例(诊断时的平均年龄为 7.3±3.4 岁,病程为 6.1±4.6 年)和 51 例对照(诊断时的平均年龄为 5.0±3.4 岁,病程为 5.7±3.9 年)。cSLE 病例的家族性 SLE 发生率高于对照组(38%比 7.8%;p<0.001)。与 ACR 1997(49%、57%、66%)和 SLICC 2012(76%、84%、86%)相比,EULAR/ACR-2019 标准的敏感性(81%、88%、89%)更高;而 ACR 1997 标准的特异性(96%)在首次就诊、首次随访和末次随访时均高于 SLICC 2012(94%)和 EULAR/ACR-2019(90%)。当我们将 ACR/EULAR 2019 的阈值评分提高到≥13 分,而不是传统的≥10 分,特异性(96%)提高了,但敏感性(首次就诊、首次随访和末次随访时的 76%、83%和 84%)降低了。
在本 cSLE 人群中,EULAR/ACR 2019 在初始表现、第一年和末次随访中表现更好。需要进一步的跨国研究来验证新提出的 ACR/EULAR 2019 分类标准在 cSLE 中的适当截断值,以提高 cSLE 分类的早期敏感性和特异性。